Asymmetric synthesis ofl-6-hydroxynorleucine from 2-keto-6-hydroxyhexanoic acid using a branched-chain aminotransferase
摘要:
L-6-Hydroxynorleucine was synthesized from 2-keto-6-hydroxyhexanoic acid using branched-chain aminotransferase from Escherichia coli with L-glutamate as an amino donor. Since the branched-chain aminotransferase was severely inhibited by 2-ketoglutarate, the branched-chain aminotransferase reaction was coupled with aspartate aminotransferase and pyruvate decarboxylase. Aspartate aminotransferase converted the inhibitory 2-ketoglutarate back to L-glutamate by using L-aspartate as an amino donor. On the other hand, pyruvate decarboxylase further shifted the reaction equilibrium towards L-6-hydroxynorleucine through decarboxylation of pyruvate to acetaldehyde. The concerted action of the three enzymes significantly enhanced the yield compared to that of branched-chain aminotransferase alone. In the coupled reaction, 90.2 mM L-6-hydroxynorleucine (> 99% ee) was produced from 100 mM 2-keto-6-hydroxyhexanoic acid, whereas in a single branched-chain aminotransferase reaction only 22.5 mM L-6-hydroxynorleucine (> 99% ee) was produced.
Paul; Tchelitcheff, Bulletin de la Societe Chimique de France, 1952, p. 808,812
作者:Paul、Tchelitcheff
DOI:——
日期:——
Biocatalytic synthesis of chiral intermediates for antiviral and antihypertensive drugs
作者:Ramesh N. Patel
DOI:10.1007/s11746-999-0139-7
日期:1999.11
AbstractThe chiral intermediate (1S,2R) [3‐chloro‐2‐hydroxy‐1‐(phenylmethyl)propyl] carbamic acid, 1,1‐dimethylethyl ester 2a was prepared for the total synthesis of a human immunodeficiency virus protease inhibitor, BMS‐186318. The stereoselective reduction of (1S) [3‐chloro‐2‐oxo‐1(phenylmethyl)propyl] carbamic acid, 1,1‐dimethylethyl ester 1 was carried out using microbial cultures, among which Streptomyces nodosus SC 13149 efficiently reduced 1 to 2a. A reaction yield of 80%, enantiomeric excess (e.e.) of 99.8%, and diastereomeric purity of 99% were obtained for chiral alcohol 2a. Chiral l‐6‐hydroxy norleucine 3, an intermediate in the synthesis of antihypertensive drug, was prepared by reductive amination of 2‐keto‐6‐hydroxyhexanoic acid 4 using beef liver glutamate dehydrogenase. The cofactor NADH required for this reaction was regenerated using glucose dehydrogenase from Bacillus sp. A reaction yield of 80% and e.e. of 99.5% were obtained for l‐6‐hydroxynorleucine 3. To avoid the lengthy chemical synthesis of the ketoacid, a second route was developed in which racemic 6‐hydroxynorleucine [readily available from hydrolysis of 5‐(4‐hydroxybutyl) hydantoin 5] was treated with d‐amino acid oxidase from Trigonopsis variabilis to selectively convert the d‐isomer of racemic 6‐hydroxynorleucine to 2‐keto‐6‐hydroxyhexanoic acid 4 and l‐6‐hydroxynorleucine 3. Subsequently, the 2‐keto‐6‐hydroxyhexanoic acid 4 was converted to l‐6‐hydroxynorleucine by reductive amination using glutamate dehydrogenase. A reaction yield of 98% and an e.e. of 99.5% were obtained.
FATTY ACID AMIDE HYDROLASE ASSAY
申请人:Warner-Lambert Company LLC
公开号:EP1851328A1
公开(公告)日:2007-11-07
A HIGH YIELD ROUTE FOR THE PRODUCTION OF COMPOUNDS FROM RENEWABLE SOURCES